Offor, O., Utay, N., Reynoso, D., Somasunderam, A., Currier, J., & Lake, J. (2018). Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy. PLoS One.

Offor, Obiageli, Netanya Utay, David Reynoso, Anoma Somasunderam, Judith Currier, e Jordan Lake. "Adiponectin and the Steatosis Marker Chi3L1 Decrease Following Switch to Raltegravir Compared to Continued PI/NNRTI-based Antiretroviral Therapy." PLoS One 2018.

Offor, Obiageli, et al. "Adiponectin and the Steatosis Marker Chi3L1 Decrease Following Switch to Raltegravir Compared to Continued PI/NNRTI-based Antiretroviral Therapy." PLoS One 2018.